Endo, Inc., a versatile company specializing in pharmaceuticals, has unveiled its new Adrenalin premixed bag, marking the first ever epinephrine in 0.9% sodium chloride injection that is FDA-approved and manufacturer-prepared for intravenous (IV) use.
“This groundbreaking ready-to-use bag of epinephrine represents progress for healthcare providers and their patients by offering a delivery system that enhances efficiency in workflow, decreases time, and minimizes medication error risk,” expressed Scott Sims, senior vice president and general manager of Endo Injectable Solutions & Generics. “We take pride in supplying essential care products such as Adrenalin bags, ensuring they’re readily available wherever and whenever needed through our TruDelivery portfolio.”
The Adrenalin premixed bag enriches the TruDelivery product range offered by Endo Injectable Solutions, providing hospitals with streamlined operational products that do not require any preparation or handling before administering to patients. Such innovations can lead to diminished waste and expenditure, improved convenience, and a decrease in error during preparation—all of which foster high-quality patient care.
This ready-to-use solution comes without the necessity for compounding, diluting, mixing, or transferring, potentially reducing waste. Its single-port design on the IV tubing limits the risk of accidentally incorporating other medications. Additionally, the product boasts a 24-month shelf life without the need for refrigeration.
Endo also provides Adrenalin in 1 mL single-dose and 30 mL multi-dose vials.
Adrenalin is primarily used to manage hypotension related to septic shock.
Endo is a multifaceted specialty pharmaceutical firm committed to revolutionizing insights into therapies that enhance lives. Its dedicated team works collaboratively to create and supply these critical treatments.